Stella Safo, MD, MPH and Michael Angarone, DO, FIDSA discuss how the Omicron variant is impacting COVID-19 treatment decisions. Topics: *Are monoclonal antibodies effective against Omicron and other variants? *Prevalence of the Omicron variant *What are the other variants of concern? *Bob is 70 with lung cancer and SARS-CoV-2 positive - how can you treat him? *Addressing racial inequities   

 

Credit available: 1.0 of AMA, ANCC, AAPA, or ACPE 

 

Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/2-9-23-episode/eval

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty 

Presenting faculty:  

Stella Safo, MD, MPH, Just Equity For Health, Founder and Executive Director, Assistant Professor Mount Sinai Health System   

Michael Angarone, DO, FIDSA, Associate Professor, Division of Infectious Diseases, Departments of Medicine and Medical Education at Northwestern University Feinberg School of Medicine 


See acast.com/privacy for privacy and opt-out information.